edwards lifesciences corp (EW:New York)
Transactions by EDWARDS LIFESCIENCES CORP (EW) in the last 6 months
Edwards Lifesciences Corp. (NYSE:EW) agreed to acquire CardiAQ Valve Technologies, Inc. from Broadview Ventures, Inc., OrbiMed Advisors, L.L.C., and others for $400 million on July 10, 2015. Of the total consideration, $350 million shall be payable in cash at closing and balance payable depending upon achievement of a European regulatory milestone. The transaction remains subject to customary closing conditions. Edwards expects that this acquisition will be slightly ...
Advent Life Sciences Fund II LP
Advent Venture Partners
Broadview Ventures, Inc.
OrbiMed Advisors, L.L.C.
Versant Ventures, Inc.
|CR Bard Inc||$193.09 USD||+2.87|
|Endo International PLC||$71.06 USD||+1.04|
|Hologic Inc||$39.42 USD||+0.39|
|Intuitive Surgical Inc||$464.87 USD||+9.30|
|Mettler-Toledo International Inc||$290.21 USD||+6.02|
|View Industry Companies|